$530 Million is the total value of 683 Capital Management, LLC's 84 reported holdings in Q2 2012. The portfolio turnover from Q1 2012 to Q2 2012 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2012 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IRSA INVERSIONES Y REP S A | 42 | Q3 2023 | 2.9% |
CRESUD S A C I F Y A | 42 | Q2 2024 | 3.3% |
ENOVA INTL INC | 36 | Q1 2024 | 8.2% |
UNIQURE NV | 31 | Q2 2024 | 4.1% |
INSPIRED ENTMT INC | 31 | Q2 2024 | 2.3% |
CARVANA CO | 27 | Q2 2024 | 14.2% |
FENNEC PHARMACEUTICALS INC | 27 | Q1 2024 | 0.9% |
MICRON TECHNOLOGY INC | 26 | Q1 2023 | 3.2% |
GALMED PHARMACEUTICALS LTD | 25 | Q1 2020 | 1.2% |
ALNYLAM PHARMACEUTICALS INC | 24 | Q2 2022 | 3.2% |
View 683 Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Perceptive Capital Solutions Corp | June 24, 2024 | 500,000 | 5.6% |
Modular Medical, Inc. | March 01, 2024 | 2,211,099 | 7.0% |
ARYA Sciences Acquisition Corp VSold out | February 14, 2024 | 0 | 0.0% |
Cactus Acquisition Corp. 1 Ltd | February 14, 2024 | 450,000 | 8.9% |
Calidi Biotherapeutics, Inc. | February 14, 2024 | 675,758 | 1.9% |
Cardlytics, Inc. | February 14, 2024 | 1,758,462 | 4.6% |
Concord Acquisition Corp IISold out | February 14, 2024 | 0 | 0.0% |
Concord Acquisition Corp III | February 14, 2024 | 134,938 | 3.4% |
Counter Press Acquisition CorpSold out | February 14, 2024 | 0 | 0.0% |
Eiger BioPharmaceuticals, Inc. | February 14, 2024 | 70,000 | 4.7% |
View 683 Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
SC 13G | 2024-06-24 |
13F-HR | 2024-05-15 |
SC 13G | 2024-03-01 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View 683 Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.